Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Correction: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy.

Petrelli A, Carollo R, Cargnelutti M, Iovino F, Callari M, Cimino D, Todaro M, Mangiapane LR, Giammona A, Cordova A, Montemurro F, Taverna D, Daidone MG, Stassi G, Giordano S.

Oncotarget. 2019 Aug 13;10(48):5003-5004. doi: 10.18632/oncotarget.27151. eCollection 2019 Aug 13.

2.

POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients.

Baird RD, van Rossum AGJ, Oliveira M, Beelen K, Gao M, Schrier M, Mandjes IAM, Garcia-Corbacho J, Vallier AL, Dougall G, van Werkhoven E, Linossi C, Kumar S, van Tinteren H, Callari M, Beddowes E, Perez-Garcia JM, Rosing H, Platte E, Nederlof P, Schot M, de Vries Schultink A, Bernards R, Saura C, Gallagher W, Cortès J, Caldas C, Linn SC.

Clin Cancer Res. 2019 Nov 15;25(22):6598-6605. doi: 10.1158/1078-0432.CCR-19-0508. Epub 2019 Aug 22.

PMID:
31439579
3.

Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups.

Rueda OM, Sammut SJ, Seoane JA, Chin SF, Caswell-Jin JL, Callari M, Batra R, Pereira B, Bruna A, Ali HR, Provenzano E, Liu B, Parisien M, Gillett C, McKinney S, Green AR, Murphy L, Purushotham A, Ellis IO, Pharoah PD, Rueda C, Aparicio S, Caldas C, Curtis C.

Nature. 2019 Mar;567(7748):399-404. doi: 10.1038/s41586-019-1007-8. Epub 2019 Mar 13.

4.

Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA.

Gao M, Callari M, Beddowes E, Sammut SJ, Grzelak M, Biggs H, Jones L, Boumertit A, Linn SC, Cortes J, Oliveira M, Baird R, Chin SF, Caldas C.

Genome Med. 2019 Jan 4;11(1):1. doi: 10.1186/s13073-018-0611-9.

5.

Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer.

Andriani F, Landoni E, Mensah M, Facchinetti F, Miceli R, Tagliabue E, Giussani M, Callari M, De Cecco L, Colombo MP, Roz L, Pastorino U, Sozzi G.

BMC Cancer. 2018 Sep 18;18(1):899. doi: 10.1186/s12885-018-4772-0.

6.

PATRI, a Genomics Data Integration Tool for Biomarker Discovery.

Ukmar G, Melloni GEM, Raddrizzani L, Rossi P, Di Bella S, Pirchio MR, Vescovi M, Leone A, Callari M, Cesarini M, Somaschini A, Della Vedova G, Daidone MG, Pettenella M, Isacchi A, Bosotti R.

Biomed Res Int. 2018 Jun 28;2018:2012078. doi: 10.1155/2018/2012078. eCollection 2018.

7.

Predicting and Understanding Cancer Response to Treatment.

Callari M, Gandellini P, Skvortsova I, Span PN.

Dis Markers. 2018 May 29;2018:6159214. doi: 10.1155/2018/6159214. eCollection 2018. No abstract available.

8.

Dissecting Time- from Tumor-Related Gene Expression Variability in Bilateral Breast Cancer.

Callari M, Dugo M, Miodini P, Veneroni S, Bianchini G, Daidone MG, Cappelletti V.

Int J Mol Sci. 2018 Jan 9;19(1). pii: E196. doi: 10.3390/ijms19010196.

9.

Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts.

Callari M, Batra AS, Batra RN, Sammut SJ, Greenwood W, Clifford H, Hercus C, Chin SF, Bruna A, Rueda OM, Caldas C.

BMC Genomics. 2018 Jan 5;19(1):19. doi: 10.1186/s12864-017-4414-y.

10.

Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.

Merlino G, Miodini P, Callari M, D'Aiuto F, Cappelletti V, Daidone MG.

Mol Oncol. 2017 Oct;11(10):1399-1412. doi: 10.1002/1878-0261.12107. Epub 2017 Aug 22.

11.

The Effect of Drug Loading on Micelle Properties: Solid-State NMR as a Tool to Gain Structural Insight.

Callari M, De Souza PL, Rawal A, Stenzel MH.

Angew Chem Int Ed Engl. 2017 Jul 10;56(29):8441-8445. doi: 10.1002/anie.201701471. Epub 2017 Jun 1.

PMID:
28570761
12.

Involvement of AF1q/MLLT11 in the progression of ovarian cancer.

Tiberio P, Lozneanu L, Angeloni V, Cavadini E, Pinciroli P, Callari M, Carcangiu ML, Lorusso D, Raspagliesi F, Pala V, Daidone MG, Appierto V.

Oncotarget. 2017 Apr 4;8(14):23246-23264. doi: 10.18632/oncotarget.15574.

13.

Intersect-then-combine approach: improving the performance of somatic variant calling in whole exome sequencing data using multiple aligners and callers.

Callari M, Sammut SJ, De Mattos-Arruda L, Bruna A, Rueda OM, Chin SF, Caldas C.

Genome Med. 2017 Apr 18;9(1):35. doi: 10.1186/s13073-017-0425-1.

14.

A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds.

Bruna A, Rueda OM, Greenwood W, Batra AS, Callari M, Batra RN, Pogrebniak K, Sandoval J, Cassidy JW, Tufegdzic-Vidakovic A, Sammut SJ, Jones L, Provenzano E, Baird R, Eirew P, Hadfield J, Eldridge M, McLaren-Douglas A, Barthorpe A, Lightfoot H, O'Connor MJ, Gray J, Cortes J, Baselga J, Marangoni E, Welm AL, Aparicio S, Serra V, Garnett MJ, Caldas C.

Cell. 2016 Sep 22;167(1):260-274.e22. doi: 10.1016/j.cell.2016.08.041. Epub 2016 Sep 15.

15.

The Prevalence of Diabetes Mellitus and Routine Hemoglobin A1c Screening in Elective Total Joint Arthroplasty Patients.

Capozzi JD, Lepkowsky ER, Callari MM, Jordan ET, Koenig JA, Sirounian GH.

J Arthroplasty. 2017 Jan;32(1):304-308. doi: 10.1016/j.arth.2016.06.025. Epub 2016 Jun 23.

PMID:
27452137
16.

PEGylated Albumin-Based Polyion Complex Micelles for Protein Delivery.

Jiang Y, Lu H, Chen F, Callari M, Pourgholami M, Morris DL, Stenzel MH.

Biomacromolecules. 2016 Mar 14;17(3):808-17. doi: 10.1021/acs.biomac.5b01537. Epub 2016 Feb 9.

PMID:
26809948
17.

Proposal of supervised data analysis strategy of plasma miRNAs from hybridisation array data with an application to assess hemolysis-related deregulation.

Landoni E, Miceli R, Callari M, Tiberio P, Appierto V, Angeloni V, Mariani L, Daidone MG.

BMC Bioinformatics. 2015 Nov 18;16:388. doi: 10.1186/s12859-015-0820-9.

18.

In-depth characterization of breast cancer tumor-promoting cell transcriptome by RNA sequencing and microarrays.

Callari M, Guffanti A, Soldà G, Merlino G, Fina E, Brini E, Moles A, Cappelletti V, Daidone MG.

Oncotarget. 2016 Jan 5;7(1):976-94. doi: 10.18632/oncotarget.5810.

19.

Subtype-Specific Metagene-Based Prediction of Outcome after Neoadjuvant and Adjuvant Treatment in Breast Cancer.

Callari M, Cappelletti V, D'Aiuto F, Musella V, Lembo A, Petel F, Karn T, Iwamoto T, Provero P, Daidone MG, Gianni L, Bianchini G.

Clin Cancer Res. 2016 Jan 15;22(2):337-45. doi: 10.1158/1078-0432.CCR-15-0757. Epub 2015 Sep 30.

20.

Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation.

Doldi V, Callari M, Giannoni E, D'Aiuto F, Maffezzini M, Valdagni R, Chiarugi P, Gandellini P, Zaffaroni N.

Oncotarget. 2015 Oct 13;6(31):31441-60. doi: 10.18632/oncotarget.5056.

21.

Complexity in the tumour microenvironment: Cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types.

Gandellini P, Andriani F, Merlino G, D'Aiuto F, Roz L, Callari M.

Semin Cancer Biol. 2015 Dec;35:96-106. doi: 10.1016/j.semcancer.2015.08.008. Epub 2015 Aug 28. Review.

PMID:
26320408
22.

Circulating Biomarkers for Prediction of Treatment Response.

Cappelletti V, Appierto V, Tiberio P, Fina E, Callari M, Daidone MG.

J Natl Cancer Inst Monogr. 2015 May;2015(51):60-3. doi: 10.1093/jncimonographs/lgv006.

PMID:
26063889
23.

miR-30e* is an independent subtype-specific prognostic marker in breast cancer.

D'Aiuto F, Callari M, Dugo M, Merlino G, Musella V, Miodini P, Paolini B, Cappelletti V, Daidone MG.

Br J Cancer. 2015 Jul 14;113(2):290-8. doi: 10.1038/bjc.2015.206. Epub 2015 Jun 9.

24.

Challenges in using circulating miRNAs as cancer biomarkers.

Tiberio P, Callari M, Angeloni V, Daidone MG, Appierto V.

Biomed Res Int. 2015;2015:731479. doi: 10.1155/2015/731479. Epub 2015 Mar 22. Review.

25.

Use of formalin-fixed paraffin-embedded samples for gene expression studies in breast cancer patients.

Musella V, Callari M, Di Buduo E, Scuro M, Dugo M, Miodini P, Bianchini G, Paolini B, Gianni L, Daidone MG, Cappelletti V.

PLoS One. 2015 Apr 6;10(4):e0123194. doi: 10.1371/journal.pone.0123194. eCollection 2015.

26.

Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtype.

Huang X, Dugo M, Callari M, Sandri M, De Cecco L, Valeri B, Carcangiu ML, Xue J, Bi R, Veneroni S, Daidone MG, Ménard S, Tagliabue E, Shao Z, Wu J, Orlandi R.

Cancer Med. 2015 Jul;4(7):1016-30. doi: 10.1002/cam4.442. Epub 2015 Mar 18.

27.

By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy.

Petrelli A, Carollo R, Cargnelutti M, Iovino F, Callari M, Cimino D, Todaro M, Mangiapane LR, Giammona A, Cordova A, Montemurro F, Taverna D, Daidone MG, Stassi G, Giordano S.

Oncotarget. 2015 Feb 10;6(4):2315-30. Erratum in: Oncotarget. 2019 Aug 13;10(48):5003-5004.

28.

Gene expression profiling of circulating tumor cells in breast cancer.

Fina E, Callari M, Reduzzi C, D'Aiuto F, Mariani G, Generali D, Pierotti MA, Daidone MG, Cappelletti V.

Clin Chem. 2015 Jan;61(1):278-89. doi: 10.1373/clinchem.2014.229476. Epub 2014 Nov 19.

29.

A lipemia-independent NanoDrop(®)-based score to identify hemolysis in plasma and serum samples.

Appierto V, Callari M, Cavadini E, Morelli D, Daidone MG, Tiberio P.

Bioanalysis. 2014 May;6(9):1215-26. doi: 10.4155/bio.13.344.

PMID:
24946922
30.

Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer.

Callari M, Musella V, Di Buduo E, Sensi M, Miodini P, Dugo M, Orlandi R, Agresti R, Paolini B, Carcangiu ML, Cappelletti V, Daidone MG.

Mol Oncol. 2014 Oct;8(7):1278-89. doi: 10.1016/j.molonc.2014.04.010. Epub 2014 May 4.

31.

Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells.

Taddei ML, Giannoni E, Morandi A, Ippolito L, Ramazzotti M, Callari M, Gandellini P, Chiarugi P.

Cell Commun Signal. 2014 Apr 1;12:24. doi: 10.1186/1478-811X-12-24.

32.

Accurate data processing improves the reliability of Affymetrix gene expression profiles from FFPE samples.

Callari M, Lembo A, Bianchini G, Musella V, Cappelletti V, Gianni L, Daidone MG, Provero P.

PLoS One. 2014 Jan 29;9(1):e86511. doi: 10.1371/journal.pone.0086511. eCollection 2014. Erratum in: PLoS One. 2014;9(4):e95814.

33.

miR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts.

Gandellini P, Giannoni E, Casamichele A, Taddei ML, Callari M, Piovan C, Valdagni R, Pierotti MA, Zaffaroni N, Chiarugi P.

Antioxid Redox Signal. 2014 Mar 1;20(7):1045-59. doi: 10.1089/ars.2013.5292. Epub 2013 Sep 17.

34.

Measuring microRNA expression levels in oncology: from samples to data analysis.

De Cecco L, Dugo M, Canevari S, Daidone MG, Callari M.

Crit Rev Oncog. 2013;18(4):273-87. Review.

PMID:
23614615
35.

Feasibility of circulating miRNA microarray analysis from archival plasma samples.

Callari M, Tiberio P, De Cecco L, Cavadini E, Dugo M, Ghimenti C, Daidone MG, Canevari S, Appierto V.

Anal Biochem. 2013 Jun 15;437(2):123-5. doi: 10.1016/j.ab.2013.03.002. Epub 2013 Mar 13.

PMID:
23499963
36.

Bioinformatics tools for secretome analysis.

Caccia D, Dugo M, Callari M, Bongarzone I.

Biochim Biophys Acta. 2013 Nov;1834(11):2442-53. doi: 10.1016/j.bbapap.2013.01.039. Epub 2013 Feb 5. Review.

PMID:
23395702
37.

Effects of warm ischemic time on gene expression profiling in colorectal cancer tissues and normal mucosa.

Musella V, Verderio P, Reid JF, Pizzamiglio S, Gariboldi M, Callari M, Milione M, De Cecco L, Veneroni S, Pierotti MA, Daidone MG.

PLoS One. 2013;8(1):e53406. doi: 10.1371/journal.pone.0053406. Epub 2013 Jan 7. Erratum in: PLoS One. 2013;8(6). doi:10.1371/annotation/11071e0f-4f09-4b1f-93ec-f1362610ce33. Massimo, Milione [corrected to Milione, Massimo].

38.

MicroRNA detection in plasma samples: how to treat heparinized plasma.

Tiberio P, De Cecco L, Callari M, Cavadini E, Daidone MG, Appierto V.

J Mol Diagn. 2013 Jan;15(1):138-9. doi: 10.1016/j.jmoldx.2012.08.009. No abstract available.

39.

Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues.

Callari M, Dugo M, Musella V, Marchesi E, Chiorino G, Grand MM, Pierotti MA, Daidone MG, Canevari S, De Cecco L.

PLoS One. 2012;7(9):e45105. doi: 10.1371/journal.pone.0045105. Epub 2012 Sep 13. Erratum in: PLoS One. 2013;8(5). doi:10.1371/annotation/c38405cc-dc33-424e-bfcb-14de73f5c8c8.

40.

AF1q: a novel mediator of basal and 4-HPR-induced apoptosis in ovarian cancer cells.

Tiberio P, Cavadini E, Callari M, Daidone MG, Appierto V.

PLoS One. 2012;7(6):e39968. doi: 10.1371/journal.pone.0039968. Epub 2012 Jun 26.

41.

miR-205 regulates basement membrane deposition in human prostate: implications for cancer development.

Gandellini P, Profumo V, Casamichele A, Fenderico N, Borrelli S, Petrovich G, Santilli G, Callari M, Colecchia M, Pozzi S, De Cesare M, Folini M, Valdagni R, Mantovani R, Zaffaroni N.

Cell Death Differ. 2012 Nov;19(11):1750-60. doi: 10.1038/cdd.2012.56. Epub 2012 May 4.

42.

Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer.

Callari M, Cappelletti V, De Cecco L, Musella V, Miodini P, Veneroni S, Gariboldi M, Pierotti MA, Daidone MG.

Breast Cancer Res Treat. 2011 Jun;127(3):601-10. doi: 10.1007/s10549-010-1015-8. Epub 2010 Jul 13.

PMID:
20625818
43.

miR-21: an oncomir on strike in prostate cancer.

Folini M, Gandellini P, Longoni N, Profumo V, Callari M, Pennati M, Colecchia M, Supino R, Veneroni S, Salvioni R, Valdagni R, Daidone MG, Zaffaroni N.

Mol Cancer. 2010 Jan 21;9:12. doi: 10.1186/1476-4598-9-12.

44.

Impact of biospecimens handling on biomarker research in breast cancer.

De Cecco L, Musella V, Veneroni S, Cappelletti V, Bongarzone I, Callari M, Valeri B, Pierotti MA, Daidone MG.

BMC Cancer. 2009 Nov 24;9:409. doi: 10.1186/1471-2407-9-409.

45.

A transcriptional sketch of a primary human breast cancer by 454 deep sequencing.

Guffanti A, Iacono M, Pelucchi P, Kim N, Soldà G, Croft LJ, Taft RJ, Rizzi E, Askarian-Amiri M, Bonnal RJ, Callari M, Mignone F, Pesole G, Bertalot G, Bernardi LR, Albertini A, Lee C, Mattick JS, Zucchi I, De Bellis G.

BMC Genomics. 2009 Apr 20;10:163. doi: 10.1186/1471-2164-10-163.

46.

Reciprocal regulation of p63 by C/EBP delta in human keratinocytes.

Borrelli S, Testoni B, Callari M, Alotto D, Castagnoli C, Romano RA, Sinha S, Viganò AM, Mantovani R.

BMC Mol Biol. 2007 Sep 28;8:85.

47.

[Mediterranean anemia in 124 Sicilian pregnant women].

Pepe F, Pepe P, Rotolo N, Donia A, Callari MR, Grillo S.

Minerva Ginecol. 1997 Jun;49(6):277-81. Italian.

PMID:
9289668

Supplemental Content

Loading ...
Support Center